<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <link rel="icon" type="image/svg+xml" href="data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 32 32'%3E%3Crect width='32' height='32' rx='6' fill='%230f2340'/%3E%3Cpath d='M 22 4 C 3 4 3 28 22 28' fill='none' stroke='%233d9e9e' stroke-width='2.5' stroke-linecap='round'/%3E%3Cpath d='M 22 4 C 3 4 3 28 22 28' fill='none' stroke='%23c8a96e' stroke-width='5' stroke-dasharray='7 9999' stroke-dashoffset='-12' stroke-linecap='round'/%3E%3C/svg%3E" />
  <link rel="canonical" href="https://cheewaiwong.com/articles/article-myopia-children.html" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Myopia in Children Singapore: Prevention & Control | Dr Chee Wai Wong</title>
  <meta name="description" content="Why childhood myopia matters for lifelong eye health. Dr Chee Wai Wong explains myopia progression, control options (atropine, ortho-K, outdoor time), and when a retinal specialist should be involved." />
  <meta name="keywords" content="myopia children Singapore, childhood myopia control, atropine eye drops myopia, orthokeratology Singapore, myopia specialist Singapore, high myopia prevention" />
  <meta property="og:type" content="article" />
  <meta property="og:title" content="Myopia in Children Singapore: Prevention & Control | Dr Chee Wai Wong" />
  <meta property="og:description" content="Why childhood myopia matters for lifelong eye health. Dr Chee Wai Wong explains myopia progression, control options (atropine, ortho-K, outdoor time), and when a retinal specialist should be involved." />
  <meta property="og:url" content="https://cheewaiwong.com/articles/article-myopia-children.html" />
  <meta property="og:site_name" content="Dr Chee Wai Wong | Vitreoretinal Surgeon Singapore" />
  <meta name="twitter:card" content="summary_large_image" />
  <meta name="twitter:title" content="Myopia in Children Singapore: Prevention & Control | Dr Chee Wai Wong" />
  <meta name="twitter:description" content="Why childhood myopia matters for lifelong eye health. Dr Chee Wai Wong explains myopia progression, control options (atropine, ortho-K, outdoor time), and when a retinal specialist should be involved." />
  <meta property="og:image" content="https://cheewaiwong.com/images/dr-chee-wai-wong.jpg" />
  <meta name="twitter:image" content="https://cheewaiwong.com/images/dr-chee-wai-wong.jpg" />
  <meta name="robots" content="index, follow" />
  <link rel="preconnect" href="https://fonts.googleapis.com" />
  <link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:ital,wght@0,300;0,400;0,600;1,300;1,400&family=DM+Sans:wght@300;400;500&display=swap" rel="stylesheet" />
  <style>
    *, *::before, *::after { box-sizing: border-box; margin: 0; padding: 0; }
    :root { --navy: #0f2340; --teal: #2a7c7c; --teal-light: #3d9e9e; --gold: #c8a96e; --cream: #faf7f2; --text: #1a2e3b; --muted: #6b7f8a; --border: rgba(15,35,64,0.1); --urgent: #c0392b; --urgent-bg: #fdf2f0; }
    html { scroll-behavior: smooth; }
    body { font-family: 'DM Sans', sans-serif; background: var(--cream); color: var(--text); line-height: 1.7; }
    nav { position: fixed; top: 0; left: 0; right: 0; z-index: 200; display: flex; align-items: center; justify-content: space-between; padding: 1.25rem 4rem; background: rgba(250,247,242,0.96); backdrop-filter: blur(12px); border-bottom: 1px solid var(--border); }
    .nav-logo { font-family: 'Cormorant Garamond', serif; font-size: 1.2rem; font-weight: 600; color: var(--navy); text-decoration: none; }
    .nav-logo span { color: var(--teal); }
    .nav-links { display: flex; gap: 2.5rem; list-style: none; }
    .nav-links a { font-size: 0.82rem; font-weight: 500; letter-spacing: 0.08em; text-transform: uppercase; color: var(--muted); text-decoration: none; transition: color 0.2s; }
    .nav-links a:hover { color: var(--teal); }
    .nav-cta { background: var(--navy) !important; color: #fff !important; padding: 0.55rem 1.4rem; border-radius: 2rem; }
    .article-hero { background: linear-gradient(135deg, #0e1a2e 0%, #0a2040 50%, var(--navy) 100%); padding: 8rem 4rem 5rem; position: relative; overflow: hidden; }
    .article-hero::before { content: ''; position: absolute; top: -40px; right: 8%; width: 420px; height: 420px; border-radius: 50%; background: radial-gradient(circle, rgba(42,90,140,0.12) 0%, transparent 65%); }
    .article-hero-inner { max-width: 800px; margin: 0 auto; position: relative; z-index: 1; }
    .article-meta { display: flex; gap: 1rem; align-items: center; flex-wrap: wrap; margin-bottom: 1.5rem; }
    .article-tag { font-size: 0.65rem; font-weight: 700; letter-spacing: 0.15em; text-transform: uppercase; padding: 0.3rem 0.85rem; border-radius: 2rem; }
    .tag-macular { background: rgba(200,169,110,0.15); color: var(--gold); border: 1px solid rgba(200,169,110,0.25); }
    .tag-guide { background: rgba(42,124,124,0.2); color: var(--teal-light); border: 1px solid rgba(42,124,124,0.2); }
    .tag-emergency { background: rgba(192,57,43,0.18); color: #e87060; border: 1px solid rgba(192,57,43,0.25); }
    .tag-myopia { background: rgba(42,90,140,0.2); color: #6ea8d8; border: 1px solid rgba(42,90,140,0.25); }
    .tag-cataract { background: rgba(120,80,160,0.18); color: #b08ed8; border: 1px solid rgba(120,80,160,0.25); }
    .article-date { font-size: 0.78rem; color: rgba(255,255,255,0.3); }
    .article-hero h1 { font-family: 'Cormorant Garamond', serif; font-size: clamp(2rem, 4.5vw, 3.2rem); font-weight: 300; color: #fff; line-height: 1.12; margin-bottom: 1.25rem; }
    .article-hero h1 strong { font-weight: 600; }
    .article-hero .lead { font-size: 1.08rem; font-weight: 300; line-height: 1.75; color: rgba(255,255,255,0.6); max-width: 640px; }
    .article-byline { margin-top: 2rem; display: flex; align-items: center; gap: 1rem; }
    .byline-avatar { width: 42px; height: 42px; border-radius: 50%; background: var(--teal); display: flex; align-items: center; justify-content: center; font-family: 'Cormorant Garamond', serif; font-size: 1rem; color: #fff; flex-shrink: 0; }
    .byline-name { font-size: 0.9rem; font-weight: 500; color: #fff; }
    .byline-cred { font-size: 0.75rem; color: rgba(255,255,255,0.4); }
    .article-layout { display: grid; grid-template-columns: 1fr 280px; gap: 4rem; max-width: 1100px; margin: 0 auto; padding: 4rem 4rem 6rem; }
    .article-body h2 { font-family: 'Cormorant Garamond', serif; font-size: 1.9rem; font-weight: 500; color: var(--navy); line-height: 1.2; margin: 2.5rem 0 1rem; }
    .article-body h3 { font-family: 'Cormorant Garamond', serif; font-size: 1.4rem; font-weight: 500; color: var(--navy); margin: 2rem 0 0.75rem; }
    .article-body p { font-size: 0.97rem; line-height: 1.8; color: var(--text); margin-bottom: 1.25rem; font-weight: 300; }
    .article-body p strong { font-weight: 600; color: var(--navy); }
    .article-body ul, .article-body ol { margin: 0.75rem 0 1.25rem 1.25rem; }
    .article-body li { font-size: 0.95rem; line-height: 1.75; color: var(--text); margin-bottom: 0.4rem; font-weight: 300; }
    .article-body li strong { font-weight: 600; }
    .pull-quote { border-left: 3px solid var(--teal); padding: 1rem 1.5rem; margin: 2rem 0; background: rgba(42,124,124,0.04); border-radius: 0 0.75rem 0.75rem 0; }
    .pull-quote p { font-family: 'Cormorant Garamond', serif; font-size: 1.2rem; font-style: italic; font-weight: 400; color: var(--navy); line-height: 1.55; margin: 0; }
    .pull-quote cite { display: block; font-size: 0.75rem; font-style: normal; color: var(--muted); margin-top: 0.5rem; font-family: 'DM Sans', sans-serif; }
    .info-box { background: rgba(42,124,124,0.06); border: 1px solid rgba(42,124,124,0.15); border-radius: 1rem; padding: 1.5rem 1.75rem; margin: 1.5rem 0; }
    .info-box h4 { font-size: 0.75rem; font-weight: 700; letter-spacing: 0.12em; text-transform: uppercase; color: var(--teal); margin-bottom: 0.75rem; }
    .info-box p, .info-box li { font-size: 0.9rem; color: var(--text); line-height: 1.65; font-weight: 300; }
    .info-box ul { padding-left: 1rem; }
    .info-box li { margin-bottom: 0.3rem; }
    .urgent-box { background: var(--urgent-bg); border: 1px solid rgba(192,57,43,0.2); border-radius: 1rem; padding: 1.5rem 1.75rem; margin: 1.5rem 0; }
    .urgent-box h4 { font-size: 0.75rem; font-weight: 700; letter-spacing: 0.12em; text-transform: uppercase; color: var(--urgent); margin-bottom: 0.75rem; }
    .urgent-box p, .urgent-box li { font-size: 0.9rem; color: var(--text); line-height: 1.65; font-weight: 300; }
    .urgent-box ul { padding-left: 1rem; }
    .urgent-box li { margin-bottom: 0.3rem; }
    .decision-box { background: var(--navy); border-radius: 1rem; padding: 1.75rem; margin: 2rem 0; }
    .decision-box h4 { font-size: 0.75rem; font-weight: 700; letter-spacing: 0.12em; text-transform: uppercase; color: var(--gold); margin-bottom: 1.25rem; }
    .decision-col { margin-bottom: 1rem; }
    .decision-col:last-child { margin-bottom: 0; }
    .decision-label { font-size: 0.7rem; font-weight: 700; letter-spacing: 0.1em; text-transform: uppercase; padding: 0.25rem 0.75rem; border-radius: 2rem; display: inline-block; margin-bottom: 0.5rem; }
    .dl-watch { background: rgba(42,124,124,0.25); color: var(--teal-light); }
    .dl-operate { background: rgba(200,169,110,0.2); color: var(--gold); }
    .dl-urgent { background: rgba(192,57,43,0.25); color: #e87060; }
    .decision-col ul { padding-left: 1rem; }
    .decision-col li { font-size: 0.85rem; color: rgba(255,255,255,0.65); line-height: 1.65; margin-bottom: 0.3rem; font-weight: 300; }
    .grade-grid { display: grid; grid-template-columns: repeat(2, 1fr); gap: 1rem; margin: 1.5rem 0; }
    .grade-card { background: #fff; border: 1px solid var(--border); border-radius: 0.75rem; padding: 1.2rem; }
    .grade-num { font-family: 'Cormorant Garamond', serif; font-size: 2rem; font-weight: 300; color: var(--teal); line-height: 1; margin-bottom: 0.3rem; }
    .grade-name { font-size: 0.78rem; font-weight: 700; color: var(--navy); margin-bottom: 0.3rem; }
    .grade-desc { font-size: 0.8rem; color: var(--muted); line-height: 1.6; font-weight: 300; }
    .surgery-step { display: flex; gap: 1rem; margin-bottom: 1.25rem; align-items: flex-start; }
    .step-num { background: var(--navy); color: var(--gold); font-family: 'Cormorant Garamond', serif; font-size: 1rem; font-weight: 600; width: 32px; height: 32px; border-radius: 50%; display: flex; align-items: center; justify-content: center; flex-shrink: 0; margin-top: 2px; }
    .step-body h4 { font-size: 0.95rem; font-weight: 600; color: var(--navy); margin-bottom: 0.25rem; }
    .step-body p { font-size: 0.88rem; color: var(--muted); margin: 0; line-height: 1.6; font-weight: 300; }
    .stat-callout { background: var(--navy); border-radius: 1rem; padding: 1.5rem; margin: 1.75rem 0; text-align: center; }
    .stat-callout .n { font-family: 'Cormorant Garamond', serif; font-size: 3rem; font-weight: 300; color: var(--gold); line-height: 1; }
    .stat-callout .l { font-size: 0.82rem; color: rgba(255,255,255,0.5); font-weight: 300; margin-top: 0.3rem; line-height: 1.5; }
    .sidebar-card { background: #fff; border-radius: 1rem; border: 1px solid var(--border); padding: 1.5rem; margin-bottom: 1.5rem; }
    .sidebar-label { font-size: 0.65rem; font-weight: 700; letter-spacing: 0.15em; text-transform: uppercase; color: var(--teal); margin-bottom: 1rem; }
    .sidebar-stat { text-align: center; padding: 0.75rem 0; border-bottom: 1px solid var(--border); }
    .sidebar-stat:last-child { border-bottom: none; padding-bottom: 0; }
    .sidebar-stat .n { font-family: 'Cormorant Garamond', serif; font-size: 1.8rem; font-weight: 300; color: var(--navy); }
    .sidebar-stat .l { font-size: 0.72rem; color: var(--muted); line-height: 1.5; }
    .btn-book { display: block; background: var(--navy); color: #fff; text-align: center; padding: 0.85rem 1rem; border-radius: 2rem; text-decoration: none; font-size: 0.85rem; font-weight: 500; margin-top: 1rem; transition: background 0.2s; }
    .btn-book:hover { background: var(--teal); }
    .toc-list { list-style: none; }
    .toc-list li { border-bottom: 1px solid var(--border); }
    .toc-list li:last-child { border-bottom: none; }
    .toc-list a { display: block; font-size: 0.82rem; color: var(--muted); text-decoration: none; padding: 0.6rem 0; transition: color 0.2s; font-weight: 300; }
    .toc-list a:hover { color: var(--teal); }
    .article-footer-cta { background: var(--navy); padding: 4rem; text-align: center; }
    .article-footer-cta h2 { font-family: 'Cormorant Garamond', serif; font-size: clamp(1.8rem, 3vw, 2.4rem); font-weight: 300; color: #fff; margin-bottom: 0.75rem; }
    .article-footer-cta h2 strong { font-weight: 600; }
    .article-footer-cta p { font-size: 0.9rem; color: rgba(255,255,255,0.45); font-weight: 300; max-width: 480px; margin: 0 auto 2rem; line-height: 1.7; }
    .btn-gold { display: inline-block; background: var(--gold); color: var(--navy); padding: 0.85rem 2.25rem; border-radius: 3rem; font-size: 0.88rem; font-weight: 600; text-decoration: none; transition: all 0.25s; }
    .btn-gold:hover { background: #d9bf91; transform: translateY(-2px); }
    .related-articles { background: var(--cream); padding: 4rem; }
    .related-inner { max-width: 1100px; margin: 0 auto; }
    .related-grid { display: grid; grid-template-columns: repeat(3, 1fr); gap: 1.25rem; margin-top: 1.5rem; }
    .related-card { background: #fff; border-radius: 1rem; border: 1px solid var(--border); padding: 1.5rem; text-decoration: none; transition: box-shadow 0.25s, transform 0.2s; display: block; }
    .related-card:hover { box-shadow: 0 8px 32px rgba(15,35,64,0.1); transform: translateY(-3px); }
    .related-tag { font-size: 0.62rem; font-weight: 700; letter-spacing: 0.12em; text-transform: uppercase; color: var(--teal); margin-bottom: 0.5rem; }
    .related-title { font-family: 'Cormorant Garamond', serif; font-size: 1.1rem; font-weight: 500; color: var(--navy); line-height: 1.35; margin-bottom: 0.4rem; }
    .related-desc { font-size: 0.8rem; color: var(--muted); line-height: 1.6; font-weight: 300; }
    footer { background: #07141f; color: rgba(255,255,255,0.35); padding: 2rem 4rem; display: flex; justify-content: space-between; align-items: center; font-size: 0.8rem; flex-wrap: wrap; gap: 1rem; }
    footer a { color: rgba(255,255,255,0.35); text-decoration: none; }
    footer a:hover { color: var(--teal-light); }
    .wa-float { position: fixed; bottom: 28px; right: 28px; z-index: 500; width: 50px; height: 50px; background: #25d366; border-radius: 50%; display: flex; align-items: center; justify-content: center; box-shadow: 0 4px 18px rgba(37,211,102,0.38); text-decoration: none; transition: background 0.2s, transform 0.2s; }
    .wa-float:hover { background: #20bd5a; transform: translateY(-2px); }
    .checklist-box { background: rgba(42,124,124,0.06); border: 1px solid rgba(42,124,124,0.15); border-radius: 1rem; padding: 1.5rem 1.75rem; margin: 1.5rem 0; }
    .checklist-box h4 { font-size: 0.75rem; font-weight: 700; letter-spacing: 0.12em; text-transform: uppercase; color: var(--teal); margin-bottom: 0.75rem; }
    .checklist-box ul { padding-left: 1.5rem; }
    .checklist-box li { font-size: 0.9rem; color: var(--text); line-height: 1.65; font-weight: 300; margin-bottom: 0.5rem; }
    .checklist-box li::marker { color: var(--teal); font-weight: 600; }
    .comparison-grid { display: grid; grid-template-columns: repeat(2, 1fr); gap: 1.5rem; margin: 1.5rem 0; }
    .comparison-card { background: #fff; border: 1px solid var(--border); border-radius: 0.75rem; padding: 1.5rem; }
    .comparison-card h4 { font-size: 0.85rem; font-weight: 600; color: var(--navy); margin-bottom: 0.75rem; }
    .comparison-card ul { padding-left: 1rem; }
    .comparison-card li { font-size: 0.85rem; color: var(--text); line-height: 1.6; font-weight: 300; margin-bottom: 0.3rem; }
    .risk-table { width: 100%; border-collapse: collapse; margin: 1.5rem 0; background: #fff; border-radius: 0.75rem; overflow: hidden; border: 1px solid var(--border); }
    .risk-table thead { background: rgba(42,124,124,0.08); }
    .risk-table th { padding: 0.85rem; text-align: left; font-size: 0.75rem; font-weight: 700; color: var(--navy); letter-spacing: 0.08em; text-transform: uppercase; border-bottom: 1px solid var(--border); }
    .risk-table td { padding: 0.85rem; font-size: 0.85rem; color: var(--text); font-weight: 300; border-bottom: 1px solid var(--border); }
    .risk-table tr:last-child td { border-bottom: none; }
    @media (max-width: 900px) {
      nav { padding: 1rem 1.5rem; } .nav-links { display: none; }
      .article-hero { padding: 7rem 1.5rem 4rem; }
      .article-layout { grid-template-columns: 1fr; gap: 0; padding: 2.5rem 1.5rem 4rem; }
      .article-sidebar { order: -1; display: grid; grid-template-columns: 1fr 1fr; gap: 1rem; }
      .grade-grid { grid-template-columns: 1fr; }
      .comparison-grid { grid-template-columns: 1fr; }
      .related-articles, .article-footer-cta { padding: 3rem 1.5rem; }
      .related-grid { grid-template-columns: 1fr; }
      footer { flex-direction: column; text-align: center; padding: 1.5rem; }
    }
  </style>
  <script type="application/ld+json">
  {
    "@context": "https://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
      {"@type": "ListItem", "position": 1, "name": "Home", "item": "https://cheewaiwong.com/"},
      {"@type": "ListItem", "position": 2, "name": "Patient Information", "item": "https://cheewaiwong.com/#education"},
      {"@type": "ListItem", "position": 3, "name": "Myopia in Children: Prevention, Control & Long-Term Eye Health", "item": "https://cheewaiwong.com/articles/article-myopia-children.html"}
    ]
  }
  </script>
  <script type="application/ld+json">
  {
    "@context": "https://schema.org",
    "@type": "MedicalWebPage",
    "name": "Myopia in Children: Prevention, Control & Long-Term Eye Health",
    "description": "Why childhood myopia matters for lifelong eye health. Dr Chee Wai Wong explains myopia progression, control options (atropine, ortho-K, outdoor time), and when a retinal specialist should be involved.",
    "url": "https://cheewaiwong.com/articles/article-myopia-children.html",
    "about": {
      "@type": "MedicalCondition",
      "name": "Myopia in Children, Childhood Myopia, Myopia Progression"
    },
    "author": {
      "@type": "Physician",
      "name": "Dr Chee Wai Wong",
      "medicalSpecialty": "Ophthalmology",
      "worksFor": {
        "@type": "MedicalOrganization",
        "name": "Asia Pacific Eye Centre",
        "address": {
          "@type": "PostalAddress",
          "streetAddress": "6A Napier Road",
          "addressLocality": "Singapore",
          "postalCode": "258500",
          "addressCountry": "SG"
        }
      }
    },
    "publisher": {
      "@type": "Organization",
      "name": "Asia Pacific Eye Centre",
      "url": "https://cheewaiwong.com"
    },
    "datePublished": "2026-02-01",
    "lastReviewed": "2026-02-23",
    "medicalAudience": {
      "@type": "PatientAudience",
      "audienceType": "Patient"
    }
  }
  </script>
  <script type="application/ld+json">
  {
    "@context": "https://schema.org",
    "@type": "FAQPage",
    "mainEntity": [
      {
        "@type": "Question",
        "name": "Why should parents worry about myopia if it runs in the family?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Family history of myopia increases your child's risk significantly. However, myopia is not just a cosmetic issue requiring glasses—it is a progressive condition involving physical elongation of the eye. High myopia (−6.00 dioptres or more) carries lifelong risks of serious eye diseases including retinal detachment, myopic macular degeneration, and glaucoma. Early detection and intervention during childhood offer the best chance of slowing progression and reducing long-term complications."
        }
      },
      {
        "@type": "Question",
        "name": "What is the difference between myopia in children and high myopia?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "All high myopia begins as childhood myopia. The distinction is severity and rate of progression. Standard myopia (up to −5.00 dioptres) with slower progression may never reach pathologic levels. However, children who develop myopia early (before age 10) or progress rapidly have a high risk of reaching −6.00 dioptres or beyond, where retinal complications become statistically significant. This is why early myopia control is important."
        }
      },
      {
        "@type": "Question",
        "name": "Can low-dose atropine eye drops stop my child's myopia from progressing?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Low-dose atropine (0.01% to 0.05%) does not stop myopia progression completely but slows it by approximately 50–70% compared to untreated children. This is significant because it reduces the final prescription and, importantly, limits the total elongation of the eye. Studies show that children starting atropine early (ages 6–8) and continuing through adolescence achieve better long-term visual outcomes with lower risk of future complications."
        }
      },
      {
        "@type": "Question",
        "name": "Is orthokeratology (ortho-K) safe for children?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Orthokeratology overnight contact lenses are safe when fitted and managed carefully by trained specialists and used with strict hygiene protocols. Children must be mature enough to handle the lenses responsibly (typically age 8 and above). The main risk is corneal infection if lenses are not cleaned and stored properly. When used correctly, ortho-K has shown excellent efficacy for slowing axial elongation and is a good alternative for children who cannot tolerate daily glasses or drops."
        }
      },
      {
        "@type": "Question",
        "name": "How much outdoor time does my child need to slow myopia?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Current evidence suggests at least 2 hours per day of outdoor time provides meaningful protection against myopia onset and slows progression in myopic children. The benefit appears to be related to bright natural light exposure, which stimulates dopamine release in the retina and inhibits axial elongation. This protective effect is independent of near work habits and works synergistically with medical interventions like atropine and ortho-K."
        }
      },
      {
        "@type": "Question",
        "name": "When should my child be seen by a retinal specialist if they have myopia?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "A baseline retinal examination by a vitreoretinal specialist is recommended if your child's myopia reaches −4.00 dioptres or above, particularly if it progressed rapidly or if there is a strong family history of high myopia or retinal complications. The specialist assesses for early structural changes and establishes a baseline for ongoing surveillance. For children with progressing high myopia (−6.00 or above), annual dilated eye examinations with OCT imaging are essential to detect complications early."
        }
      }
    ]
  }
  </script>
  <!-- Google tag (gtag.js) -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-KGBW3DHSCL"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());
    gtag('config', 'G-KGBW3DHSCL');
  </script>
</head>
<body>

<nav>
  <a class="nav-logo" href="../index.html">Dr. <span>Chee Wai</span> Wong</a>
  <ul class="nav-links">
    <li><a href="../index.html#about">About</a></li>
    <li><a href="../index.html#services">Services</a></li>
    <li><a href="../index.html#education">Patient Info</a></li>
    <li><a href="../index.html#research">Research</a></li>
    <li><a href="../blog.html">Eye Health Insights</a></li>
    <li><a href="../media.html">Media</a></li>
    <li><a href="../fees.html">Fees</a></li>
    <li><a href="../clinical-trials.html">Research</a></li>
    <li><a href="../innovations.html">Innovation</a></li>
    <li><a href="../index.html#contact" class="nav-cta">Book Appointment</a></li>
  </ul>
</nav>

<div class="article-hero">
  <div class="article-hero-inner">
    <div class="article-meta">
      <span class="article-tag tag-myopia">Myopia</span>
      <span class="article-tag tag-guide">Parent Guide</span>
      <span class="article-date">For parents seeking clarity on childhood myopia</span>
    </div>
    <h1>Myopia in Children:<br><strong>Why It Matters &<br>What Parents Can Do</strong></h1>
    <p class="lead">Singapore has one of the world's highest rates of childhood myopia: 65% of children are myopic by Primary 6, rising to 80% by age 18. Most parents focus on getting the right glasses prescription, but the real concern is what happens decades later. Every additional dioptre of myopia increases the risk of serious eye disease—understanding this risk is the first step in protecting your child's long-term vision.</p>
    <div class="article-byline">
      <div class="byline-avatar">CW</div>
      <div>
        <p class="byline-name">Dr. Chee Wai Wong</p>
        <p class="byline-cred">Vitreoretinal Surgeon · MBBS MMed FAMS PhD · Asia Pacific Eye Centre, Gleneagles Hospital</p>
      </div>
    </div>
  </div>
</div>

<div class="article-layout">
  <article class="article-body">

    <h2 id="epidemic">Singapore's Myopia Epidemic: The Numbers That Matter</h2>
    <p>Myopia has become nearly universal among East Asian children. In Singapore, the prevalence is staggering: by the end of primary school, nearly two-thirds of children are myopic. By adulthood, the figure approaches 80%.</p>

    <div class="stat-callout">
      <p class="n">65%</p>
      <p class="l">Of Singapore children myopic by Primary 6<br>Rising to 80% by age 18</p>
    </div>

    <p>This is not simply a coincidence of genetics or a global trend affecting all regions equally. Children in Singapore, Hong Kong, Taiwan, and South Korea experience myopia rates three to four times higher than children in Europe and North America, despite similar genetic ancestry. The difference is environmental: intense academic pressure, long hours of near work, and limited outdoor time during critical years of eye development.</p>

    <p>The problem is compounded by a false sense of security. Many parents believe myopia is harmless—a matter of getting the right prescription. The assumption is that once glasses are prescribed, the problem is solved. This misses a crucial point: myopia is not primarily a refractive error that can be corrected by lenses. It is a <strong>structural condition in which the eye physically elongates</strong>, and this elongation carries lifetime consequences.</p>

    <h2 id="why-it-matters">Why Myopia Matters Beyond Glasses: The Retinal Perspective</h2>
    <p>As a vitreoretinal surgeon, my perspective on myopia is shaped by what I see in the operating theatre. I see young adults in their 30s and 40s with myopic eyes suffering catastrophic retinal detachments, or patients in their 50s discovering irreversible central vision loss from myopic macular degeneration. In nearly every case, the disease process began in childhood. Understanding why requires looking at what happens inside a myopic eye.</p>

    <h3>Axial Elongation: The Core Problem</h3>
    <p>A normal adult eye measures approximately 23–24 millimetres from front to back. In myopic children, the eye begins to elongate beyond this normal length. For every additional millimetre of length, the eye becomes more myopic by approximately 2.5 to 3.00 dioptres. So a child whose eye is 25mm long has roughly −2.50 to −3.00 myopia; at 26mm, the prescription is around −5.00; at 27mm, −7.00 or higher.</p>

    <p>This elongation is progressive during childhood and adolescence. It accelerates in the first decade of life, particularly in children who develop myopia early. Without intervention, a child with −1.00 myopia at age 8 might reach −4.00 or −5.00 by age 16, and possibly −6.00 or beyond by early adulthood—crossing the threshold into pathologic myopia.</p>

    <div class="pull-quote">
      <p>"The worst mistake parents can make is to think myopia control is optional. By the time your child is a young adult, the eye has already elongated to its final length, and that cannot be undone. The window for intervention closes quickly."</p>
      <cite>— Dr. Chee Wai Wong</cite>
    </div>

    <h3>Structural Changes and Cascading Complications</h3>
    <p>As the eye elongates, every tissue inside it is stretched over a larger surface area. The retina, initially designed for a 24mm eye, thins progressively. The macula—the region responsible for central, detailed vision—becomes distorted and its blood supply becomes compromised. The peripheral retina becomes fragile and prone to tears. The optic nerve head, where the nerve enters the eye, becomes increasingly vulnerable to glaucoma.</p>

    <p>These are not theoretical risks. They are structural consequences, visible on imaging, that accumulate with each millimetre of additional length. And crucially, they are <strong>irreversible</strong>. A child whose eye has been allowed to elongate to 27mm cannot have that length reduced. Glasses and contact lenses can correct the focusing error, but they cannot undo the physical changes.</p>

    <div class="info-box">
      <h4>The Risk Multiplier</h4>
      <p>Research shows that risk of serious eye disease increases dramatically with myopia severity. A child with −6.00 myopia has:</p>
      <ul>
        <li><strong>5 times higher risk</strong> of retinal detachment</li>
        <li><strong>10+ times higher risk</strong> of myopic macular degeneration</li>
        <li><strong>3 times higher risk</strong> of glaucoma</li>
        <li><strong>Earlier onset</strong> of age-related complications</li>
      </ul>
      <p>These risks compound over a lifetime. A patient with pathologic myopia in their 30s who remains untreated faces decades of declining vision and potential blindness from preventable complications.</p>
    </div>

    <h2 id="high-myopia">When Does Myopia Become Dangerous?</h2>
    <p>The threshold for "high myopia" or "pathologic myopia" is conventionally defined as a prescription of −6.00 dioptres or more, or an axial length exceeding 26 millimetres. At this level, the structural changes in the eye become clinically significant and complications begin to appear with measurable frequency.</p>

    <p>However, risk does not start at −6.00. It increases progressively. A child with −4.50 myopia is already at elevated risk compared to the general population. By −5.50, the risk rises significantly. And by −6.00 or beyond, the eye enters a category where surveillance and sometimes preventive intervention become important.</p>

    <p>For more detail on the complications of high myopia and what to watch for, see our <a href="article-high-myopia.html">detailed guide to high myopia</a>. The key conditions to be aware of include:</p>

    <ul>
      <li><strong>Myopic Macular Degeneration (MMD)</strong> — progressive thinning and atrophy of the macula, leading to irreversible central vision loss. This is the most feared complication and the leading cause of vision loss in high myopia.</li>
      <li><strong>Retinal Detachment</strong> — the elongated eye is prone to peripheral retinal tears, which can progress to detachment if untreated. This is a surgical emergency.</li>
      <li><strong>Myopic Choroidal Neovascularisation (CNV)</strong> — abnormal blood vessel growth in the layer beneath the retina, causing acute central vision loss.</li>
      <li><strong>Myopic Traction Maculopathy</strong> — vitreoretinal traction causing the macula to split or develop a hole.</li>
      <li><strong>Glaucoma</strong> — elevated intraocular pressure damaging the optic nerve.</li>
    </ul>

    <h2 id="control">Myopia Control: What the Evidence Shows</h2>
    <p>The good news is that myopia progression can be slowed. Multiple interventions have strong evidence supporting their effectiveness. The key is to start early—ideally within a year of myopia onset—and to maintain treatment consistently through the childhood and adolescent years. Here are the evidence-based options:</p>

    <h3>Low-Dose Atropine Eye Drops</h3>
    <p>Low-dose atropine (0.01% to 0.05%) applied nightly is the most studied and most widely used myopia control treatment globally. Multiple randomised controlled trials, including landmark studies from Singapore and other East Asian centres, show that atropine reduces myopia progression by 50–70% compared to untreated children over a one-year period.</p>

    <p>The mechanism is not fully understood but is thought to involve inhibition of axial elongation rather than simple reduction of accommodation. At low doses, side effects are minimal—some children report mild pupil dilation and reduced near focus, but these effects are usually well-tolerated. Atropine does not reverse existing myopia; the child still needs glasses or contact lenses for clear vision. What it does is slow the rate at which the prescription worsens and the eye elongates.</p>

    <p>Treatment is typically started at age 6–8 years (or shortly after myopia is detected) and continued through adolescence. The long-term goal is to limit the final prescription and, more importantly, to reduce axial elongation so that the eye does not reach pathologic levels.</p>

    <h3>Orthokeratology (Ortho-K) Contact Lenses</h3>
    <p>Orthokeratology uses specially designed rigid gas-permeable contact lenses worn overnight. These lenses temporarily reshape the cornea, allowing spectacle-free or contact-free daytime vision. Beyond the refractive convenience, ortho-K lenses reduce the myopic peripheral defocus that appears to drive axial elongation. Studies show significant slowing of myopia progression—comparable to low-dose atropine—with some studies showing even greater slowing of axial elongation.</p>

    <p>Ortho-K is suitable for motivated children, typically from age 8–10 onwards. Success depends on careful lens fitting, strict hygiene protocols, and regular follow-up. The main risk is corneal infection if lenses are not properly cared for, but this is rare with proper compliance. For the right candidate, ortho-K offers an excellent non-pharmaceutical alternative to atropine, with the added benefit of daytime freedom from glasses or standard contacts.</p>

    <h3>Myopia Control Spectacle Lenses</h3>
    <p>Several newer spectacle lens designs—such as DIMS (Defocus Incorporated Multiple Segments) lenses and HAL (Highly Aspherical Lenslets) lenses—have been shown to slow myopia progression. These lenses use multiple focal zones or aspheric elements to reduce peripheral hyperopic defocus. A major multicentre trial showed DIMS lenses reduced myopia progression by approximately 60% compared to standard spectacles. These are increasingly available and represent a convenient option for children who prefer standard spectacles to drops or contact lenses.</p>

    <h3>Outdoor Time: A Protective Factor</h3>
    <p>Epidemiological research consistently shows that children who spend more time outdoors have lower rates of myopia onset and slower progression. The protective mechanism appears to involve bright outdoor light exposure triggering dopamine release in the retina, which inhibits axial elongation. Importantly, this benefit is seen even in children who spend significant time on near work activities like studying and screen time—outdoor time appears to provide independent protection.</p>

    <p>Current evidence suggests that at least <strong>2 hours per day of outdoor time</strong> provides meaningful protective effect. This is a simple, free intervention that every parent should prioritise alongside medical myopia control options.</p>

    <div class="decision-box">
      <h4>Which Myopia Control Option Is Right for Your Child?</h4>
      <div class="decision-col">
        <span class="decision-label dl-watch">Low-Dose Atropine</span>
        <ul>
          <li>Highly effective (50–70% slowing)</li>
          <li>Easiest to use (nightly drops)</li>
          <li>Minimal side effects at low doses</li>
          <li>Long-term safety well-established</li>
          <li>Can be initiated and monitored at a single retinal specialist visit</li>
        </ul>
      </div>
      <div class="decision-col">
        <span class="decision-label dl-operate">Orthokeratology</span>
        <ul>
          <li>Highly effective (60–70% slowing)</li>
          <li>Daytime spectacle-free vision</li>
          <li>Requires mature, compliant child</li>
          <li>Requires strict hygiene and regular follow-up</li>
          <li>Specialist fitting and management needed</li>
        </ul>
      </div>
      <div class="decision-col">
        <span class="decision-label dl-watch">DIMS/HAL Lenses</span>
        <ul>
          <li>Effective (50–60% slowing)</li>
          <li>Regular glasses format (familiar)</li>
          <li>No drops or lens handling</li>
          <li>Newer technology, increasingly available</li>
          <li>More expensive than standard spectacles</li>
        </ul>
      </div>
      <div class="decision-col">
        <span class="decision-label dl-urgent">Outdoor Time</span>
        <ul>
          <li>Protective effect well-established</li>
          <li>Free and simple</li>
          <li>Beneficial for overall health</li>
          <li>Works synergistically with medical options</li>
          <li>Target: ≥2 hours per day in natural light</li>
        </ul>
      </div>
    </div>

    <p><strong>Note:</strong> I prescribe atropine and provide retinal surveillance as part of a comprehensive approach to childhood myopia. For orthokeratology and DIMS/HAL lens fitting, I work closely with experienced optometrists—referring patients to trusted colleagues who specialise in these lens-based treatments. For children already under the care of a paediatric ophthalmologist or optometrist, I am happy to collaborate, focusing on the retinal side.</p>

    <h2 id="retinal-role">Dr. Wong's Role: The Retinal Specialist's Perspective</h2>
    <p>A question parents often ask is: "Should my child be seeing a retinal surgeon?" The answer depends on the severity of myopia and whether structural complications are developing.</p>

    <h3>When to See a Retinal Specialist</h3>
    <p>A baseline retinal assessment by a vitreoretinal specialist is recommended if:</p>

    <ul>
      <li><strong>Your child's myopia reaches −4.00 dioptres or above</strong>, particularly if progression is rapid</li>
      <li><strong>There is a strong family history</strong> of high myopia or retinal complications</li>
      <li><strong>Your child has been diagnosed with high myopia (−6.00 or above)</strong></li>
      <li><strong>Structural changes are detected</strong> on retinal imaging (retinal thinning, lattice degeneration, posterior staphyloma, etc.)</li>
    </ul>

    <p>The retinal specialist will perform a detailed examination including dilated fundoscopy and often OCT imaging to assess the retinal architecture, optic nerve head, and macula. This establishes a baseline and identifies any early structural changes that require ongoing surveillance.</p>

    <h3>My Full Scope in Childhood Myopia</h3>
    <p>I manage both myopia progression and its complications. For myopia control, I prescribe atropine and, for lens-based treatments (orthokeratology, DIMS/HAL lenses), I work with optometrists to coordinate fitting and ongoing management. This sits alongside my primary expertise in retinal surveillance and surgical management of complications. For many families, this integrated approach is valuable—atropine and retinal monitoring under one specialist, with lens-based options co-managed with a trusted optometrist.</p>

    <p>I diagnose and manage:</p>
    <ul>
      <li>Retinal detachments from myopic tears</li>
      <li>Myopic macular degeneration and myopic CNV</li>
      <li>Myopic traction maculopathy and macular holes</li>
      <li>Optic nerve compression from posterior staphyloma</li>
      <li>Vitreous haemorrhage and other myopia-related complications</li>
    </ul>

    <p>My involvement is both preventive and therapeutic—from initiating myopia control early, to baseline retinal assessment, to ongoing surveillance, to managing complications if they arise. For children with high myopia or early signs of structural disease, integrating myopia control with regular retinal monitoring under one specialist offers the most comprehensive protection.</p>

    <h2 id="action">What Parents Should Do Now: A Practical Checklist</h2>
    <p>You cannot control whether your child develops myopia—genetics and environment both play roles, and the environment in Singapore (academic pressure, near-work culture, limited outdoor time) creates high risk. But you can influence the outcome if myopia does develop. Here is what you should do:</p>

    <div class="checklist-box">
      <h4>Myopia Screening & Baseline Assessment</h4>
      <ul>
        <li>Annual eye examinations from age 3, even if no symptoms</li>
        <li>If myopia is detected, obtain the full prescription and axial length measurement (ask the optometrist for this)</li>
        <li>If myopia is −4.00 or higher, arrange a baseline dilated retinal examination by a retinal specialist</li>
        <li>Establish baseline OCT imaging if myopia is −5.00 or above</li>
      </ul>
    </div>

    <div class="checklist-box">
      <h4>Myopia Control Strategy</h4>
      <ul>
        <li>Discuss myopia control options (atropine, ortho-K, special lenses) with your eye doctor immediately after diagnosis</li>
        <li>Start myopia control treatment as early as possible—ideally within 6–12 months of myopia onset</li>
        <li>Ensure consistent compliance with whichever option you choose (drops, lenses, glasses, or a combination)</li>
        <li>Re-evaluate the strategy annually; some children respond better to one option than another</li>
      </ul>
    </div>

    <div class="checklist-box">
      <h4>Lifestyle Modifications</h4>
      <ul>
        <li>Aim for at least 2 hours of outdoor time daily (or more, if possible)</li>
        <li>Encourage activities that do not involve sustained near focus (sports, outdoor play)</li>
        <li>Limit continuous near work; encourage 20-20-20 breaks (every 20 minutes, look at something 20 feet away for 20 seconds)</li>
        <li>Manage screen time—no screens within 30 minutes of bedtime</li>
      </ul>
    </div>

    <div class="checklist-box">
      <h4>Ongoing Surveillance for High Myopia</h4>
      <ul>
        <li>Once myopia reaches −5.50 or above, annual dilated retinal examination is essential</li>
        <li>Annual OCT imaging of the macula and optic nerve</li>
        <li>If structural changes (lattice degeneration, retinal thinning, posterior staphyloma) are identified, more frequent monitoring may be needed (6-monthly)</li>
        <li>Baseline imaging allows the retinal specialist to detect subtle changes that may precede symptoms</li>
      </ul>
    </div>

    <div class="checklist-box">
      <h4>Know the Warning Signs</h4>
      <ul>
        <li>New or sudden increase in floaters (spots or strings in vision)</li>
        <li>Flashes of light, particularly in the periphery</li>
        <li>A shadow, veil, or curtain appearing in any part of the visual field</li>
        <li>Blurred or distorted vision in the central visual field</li>
        <li>Any of these symptoms require same-day evaluation by an eye specialist</li>
      </ul>
    </div>

    <h2 id="faq">Frequently Asked Questions</h2>

    <h3>If my child's myopia is −3.50, should I be worried yet?</h3>
    <p>Moderate myopia (−3.50) is not yet in the high-risk category, but it is significant enough to warrant discussion about myopia control, particularly if progression has been rapid or there is a strong family history. A child with −3.50 at age 10 could easily reach −6.00 by adulthood without intervention. This is exactly the population where myopia control is most effective—starting before the prescription becomes very high, while there is still time to influence final elongation.</p>

    <h3>My child is doing well in school because of intensive tutoring and near work. Can we delay myopia control?</h3>
    <p>Unfortunately, no. Delaying treatment allows progressive elongation of the eye, and the window for effective intervention narrows with each passing year. By age 12 or 13, some of the elongation has already occurred. The most effective myopia control starts early and continues consistently. It is better to start treatment now and maintain it through adolescence than to delay and find at age 16 that the prescription has reached −7.00 or higher. Treatment can be adjusted if needed, but the fundamental principle is: start early, maintain consistency.</p>

    <h3>Will glasses or contact lenses alone slow my child's myopia?</h3>
    <p>Standard spectacles and standard soft contact lenses do not slow myopia progression. Some studies suggest that contact lenses may slow progression slightly compared to spectacles, but the effect is modest. Specific myopia control tools—atropine drops, orthokeratology lenses, or special DIMS/HAL spectacle lenses—are what have evidence for significant slowing. Regular glasses are appropriate for correction but should not be used as a substitute for actual myopia control treatment.</p>

    <h3>If my child needs myopia control, how long does treatment continue?</h3>
    <p>Most myopia control treatments are continued from the time of myopia detection through mid-to-late adolescence, typically until age 16–18 when eye growth has largely stabilised. The exact duration depends on the rate of progression and the child's age. For a child with early-onset, rapidly progressing myopia, longer treatment is often needed. For slower progression, shorter duration may suffice. Your eye care specialist will discuss the expected timeline during your consultation.</p>

    <h3>Is myopia control expensive?</h3>
    <p>Cost varies depending on which option you choose. Low-dose atropine drops are relatively inexpensive and are subsidised under government health schemes in Singapore. Orthokeratology lenses are more expensive (typically SGD 100–200 per month depending on the clinic and lens type). DIMS/HAL spectacle lenses are more expensive than standard spectacles but less costly than ortho-K. Many parents find myopia control a worthwhile investment given the long-term consequences of untreated high myopia.</p>

    <h3>What if my child has already reached −6.00 myopia? Is it too late for myopia control?</h3>
    <p>It is not ideal—ideally myopia control is initiated before reaching high myopia levels. However, myopia can continue to progress even after −6.00, particularly in adolescents. Slowing progression from −6.00 to −7.00 or −8.00 is still valuable; it reduces the final prescription and limits total axial elongation. In this case, starting myopia control immediately is important, and baseline retinal assessment by a vitreoretinal specialist to check for early structural complications is essential.</p>

    <h3>Can myopia be reversed or cured?</h3>
    <p>No. Once the eye has elongated, that physical change cannot be reversed by current treatments. LASIK and other refractive surgeries correct the focusing error (so the child can see clearly without glasses), but they do not reduce axial length or reverse the structural vulnerability of the myopic eye. The goal of myopia control is to <strong>slow</strong> or <strong>limit</strong> progression, not to reverse existing myopia. This is why early intervention is so important—you want to prevent the eye from elongating excessively in the first place.</p>

  </article>

  <aside class="article-sidebar">
    <div class="sidebar-card">
      <p class="sidebar-label">On This Page</p>
      <ul class="toc-list">
        <li><a href="#epidemic">Singapore's myopia epidemic</a></li>
        <li><a href="#why-it-matters">Why it matters beyond glasses</a></li>
        <li><a href="#high-myopia">When myopia becomes dangerous</a></li>
        <li><a href="#control">Myopia control options</a></li>
        <li><a href="#retinal-role">The retinal specialist's role</a></li>
        <li><a href="#action">What parents should do</a></li>
        <li><a href="#faq">FAQs</a></li>
      </ul>
    </div>
    <div class="sidebar-card">
      <p class="sidebar-label">At a Glance</p>
      <div class="sidebar-stat"><p class="n">65%</p><p class="l">Of SG children myopic by Primary 6</p></div>
      <div class="sidebar-stat"><p class="n">5×</p><p class="l">Retinal detachment risk at −6.00 dioptre</p></div>
      <div class="sidebar-stat"><p class="n">50–70%</p><p class="l">Slowing with low-dose atropine</p></div>
      <div class="sidebar-stat"><p class="n">2 hrs</p><p class="l">Recommended outdoor time daily</p></div>
      <a href="../index.html#contact" class="btn-book">Book a Consultation</a>
    </div>
    <div class="sidebar-card">
      <p class="sidebar-label">Key Point</p>
      <p style="font-size:0.85rem; color:var(--text); font-weight:300; line-height:1.65;">Myopia is not just a cosmetic problem requiring glasses. <strong style="color:var(--navy);">High myopia carries lifelong risks</strong> of serious eye disease. Early intervention during childhood offers the best chance of slowing progression.</p>
    </div>
    <div class="sidebar-card">
      <p class="sidebar-label">Related Reading</p>
      <p style="font-size:0.82rem; color:var(--muted); margin-bottom:0.75rem; font-weight:300;">→ <a href="article-high-myopia.html" style="color:var(--teal); text-decoration:none;">High Myopia Guide</a></p>
      <p style="font-size:0.82rem; color:var(--muted); margin-bottom:0.75rem; font-weight:300;">→ <a href="article-retinal-detachment.html" style="color:var(--teal); text-decoration:none;">Retinal Detachment</a></p>
      <p style="font-size:0.82rem; color:var(--muted); font-weight:300;">→ <a href="article-floaters.html" style="color:var(--teal); text-decoration:none;">Eye Floaters & PVD</a></p>
    </div>
  </aside>
</div>

<section class="article-footer-cta">
  <h2>Concerned about your child's<br><strong>myopia and eye health?</strong></h2>
  <p>Dr. Wong provides comprehensive retinal assessments for children and young adults with myopia above −4.00 dioptres. Early baseline evaluation and ongoing surveillance are the cornerstone of protecting vision in high myopia.</p>
  <a href="../index.html#contact" class="btn-gold">Book a Consultation</a>
</section>

<section class="related-articles">
  <div class="related-inner">
    <p style="font-size:0.68rem; font-weight:600; letter-spacing:0.15em; text-transform:uppercase; color:var(--teal); margin-bottom:0.5rem;">Further Reading</p>
    <h2 style="font-family:'Cormorant Garamond',serif; font-size:1.8rem; font-weight:300; color:var(--navy);">More from Dr. Wong</h2>
    <div class="related-grid">
      <a href="article-high-myopia.html" class="related-card">
        <p class="related-tag">Advanced Myopia</p>
        <p class="related-title">High Myopia: Managing a Lifetime of Retinal Risk</p>
        <p class="related-desc">What happens when myopia reaches −6.00 dioptres and beyond. Complications, surveillance, and when treatment is needed.</p>
      </a>
      <a href="article-retinal-detachment.html" class="related-card">
        <p class="related-tag">Surgical Emergency</p>
        <p class="related-title">Retinal Detachment: Warning Signs, Surgery & Recovery</p>
        <p class="related-desc">High myopia is one of the most significant risk factors for retinal detachment. Know the warning signs.</p>
      </a>
      <a href="article-floaters.html" class="related-card">
        <p class="related-tag">Patient Guide</p>
        <p class="related-title">Eye Floaters: When to Panic, When Not To</p>
        <p class="related-desc">Floaters are common in myopic eyes. Understanding when they signal something serious could protect your vision.</p>
      </a>
    </div>
  </div>
</section>

<footer>
  <span>© 2026 Dr. Chee Wai Wong · Asia Pacific Eye Centre, Gleneagles Hospital, Singapore</span>
  <span><a href="../index.html#about">About</a> · <a href="../index.html#services">Services</a> · <a href="../index.html#research">Research</a> · <a href="../blog.html">Eye Health Insights</a> · <a href="../index.html#contact">Contact</a></span>
</footer>
<a href="https://wa.me/6592357063" class="wa-float" target="_blank" rel="noopener" aria-label="WhatsApp the clinic"><svg width="26" height="26" viewBox="0 0 24 24" fill="#fff" xmlns="http://www.w3.org/2000/svg"><path d="M17.472 14.382c-.297-.149-1.758-.867-2.03-.967-.273-.099-.471-.148-.67.15-.197.297-.767.966-.94 1.164-.173.199-.347.223-.644.075-.297-.15-1.255-.463-2.39-1.475-.883-.788-1.48-1.761-1.653-2.059-.173-.297-.018-.458.13-.606.134-.133.298-.347.446-.52.149-.174.198-.298.298-.497.099-.198.05-.371-.025-.52-.075-.149-.669-1.612-.916-2.207-.242-.579-.487-.5-.669-.51-.173-.008-.371-.01-.57-.01-.198 0-.52.074-.792.372-.272.297-1.04 1.016-1.04 2.479 0 1.462 1.065 2.875 1.213 3.074.149.198 2.096 3.2 5.077 4.487.709.306 1.262.489 1.694.625.712.227 1.36.195 1.871.118.571-.085 1.758-.719 2.006-1.413.248-.694.248-1.289.173-1.413-.074-.124-.272-.198-.57-.347m-5.421 7.403h-.004a9.87 9.87 0 01-5.031-1.378l-.361-.214-3.741.982.998-3.648-.235-.374a9.86 9.86 0 01-1.51-5.26c.001-5.45 4.436-9.884 9.888-9.884 2.64 0 5.122 1.03 6.988 2.898a9.825 9.825 0 012.893 6.994c-.003 5.45-4.437 9.884-9.885 9.884m8.413-18.297A11.815 11.815 0 0012.05 0C5.495 0 .16 5.335.157 11.892c0 2.096.547 4.142 1.588 5.945L.057 24l6.305-1.654a11.882 11.882 0 005.683 1.448h.005c6.554 0 11.89-5.335 11.893-11.893a11.821 11.821 0 00-3.48-8.413z"/></svg></a>
</body>
</html>
